Genentech updates Phase 3 Ocrevus high-dose study in people w/relapsing MS on: April 03, 2025, 10:07:08 am #1 From BusinessWire.com (April 2, 2025)--"Genentech Provides Update on Phase III Ocrevus High-Dose Study in People with Relapsing Multiple Sclerosis":https://tinyurl.com/yenj9hcm[size=78%]http://[/size] Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
